GLRA
XBI icon

Gerald L. Ray & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gerald L. Ray & Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.54M Buy
17,845
+625
+4% +$50.1K 0.19% 116
2017
Q2 		$1.33M Buy
17,220
+850
+5% +$60.3K 0.17% 122
2017
Q1 		$1.14M Buy
16,370
+1,635
+11% +$110K 0.16% 128
2016
Q4 		$872K Buy
14,735
+1,035
+8% +$63.9K 0.13% 149
2016
Q3 		$908K Sell
13,700
-500
-4% -$30.9K 0.14% 142
2016
Q2 		$768K Buy
14,200
+2,275
+19% +$125K 0.12% 151
2016
Q1 		$616K Buy
11,925
+375
+3% +$19.5K 0.1% 170
2015
Q4 		$811K Buy
11,550
+450
+4% +$30.7K 0.13% 138
2015
Q3 		$691K Buy
11,100
+150
+1% +$11.8K 0.12% 156
2015
Q2 		$921K Sell
10,950
-180
-2% -$14K 0.14% 140
2015
Q1 		$837K Hold
11,130
– – 0.13% 149
2014
Q4 		$692K Buy
11,130
+900
+9% +$51.3K 0.11% 167
2014
Q3 		$532K Buy
10,230
+300
+3% +$15.3K 0.09% 189
2014
Q2 		$510K Buy
9,930
+2,550
+35% +$115K 0.09% 191
2014
Q1 		$351K Buy
7,380
+780
+12% +$39.9K 0.06% 226
2013
Q4 		$286K Buy
6,600
+1,275
+24% +$52.8K 0.05% 239
2013
Q3 		$229K Buy
+5,325
New +$216K 0.05% 244

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Gerald L. Ray & Associates's XBI Position: Q3 2017 in Review

Gerald L. Ray & Associates increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.6% in Q3 2017, buying an estimated $50.1K and bringing the position to 17,845 shares worth $1.54M. The position accounts for 0.19% of the portfolio, ranked #116.

Gerald L. Ray & Associates first reported a position in XBI in Q3 2013 and has held it in 17 quarters since. 349 funds tracked by Wall St. Rank hold XBI as of Q3 2017.

  • Gerald L. Ray & Associates held 17,845 shares of State Street SPDR S&P Biotech ETF worth $1.54M as of Q3 2017.
  • Gerald L. Ray & Associates bought 625 State Street SPDR S&P Biotech ETF shares in Q3 2017, an estimated $50.1K.
  • State Street SPDR S&P Biotech ETF made up 0.19% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #116 holding.
  • Gerald L. Ray & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 17 quarters since.
  • 349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.